The effective treatment of malaria can be very complex: Plasmodium parasites develop in multiple stages within a complex life cycle between mosquitoes as vectors and vertebrates as hosts. For the full and effective elimination of parasites, an effective drug should be active against the earliest stages of the Plasmodium infection: liver stages (reduce the progress of the infection), blood stages (cure the clinical symptoms), and gametocytes (inhibit the transmission cycle). Towards this goal, here we report the design, the synthetic methodology, and the characterization of novel hybrid agents with combined activity against Plasmodium liver stages and blood stages and gametocytes. The divergent synthetic approach allows the access to differently linked primaquine-chloroquine hybrid templates in up to eight steps.
CITATION STYLE
Lödige, M., & Hiersch, L. (2015). Design and Synthesis of Novel Hybrid Molecules against Malaria. International Journal of Medicinal Chemistry, 2015, 1–23. https://doi.org/10.1155/2015/458319
Mendeley helps you to discover research relevant for your work.